Cinnamyl-3,4-dihydroxy-α-cyanocinnamate
Cinnamyl-3,4-dihydroxy-α-cyanocinnamate (CDC) is a potent 12/15-Lipoxygenases (LO) inhibitor. Cinnamyl-3,4-dihydroxy-α-cyanocinnamate has the potential for the research of type 1 diabetes mellitus[1].
Product Specifications
CAS Number
132465-11-3
Product Name Alternative
CDC
UNSPSC
12352005
Hazard Statement
H317, H410
Target
Lipoxygenase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease; Cancer
Assay Protocol
https://www.medchemexpress.com/cinnamyl-3-4-dihydroxy-α-cyanocinnamate.html
Purity
99.41
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
O=C(OC/C=C/C1=CC=CC=C1)/C(C#N)=C/C2=CC=C(O)C(O)=C2
Molecular Formula
C19H15NO4
Molecular Weight
321.33
Precautions
H317, H410
References & Citations
[1]Wang X, et al. 12 (S) -hydroxyeicosatetraenoic acid impairs vascular endothelial permeability by altering adherens junction phosphorylation levels and affecting the binding and dissociation of its components in high glucose-induced vascular injury. J Diabetes Investig. 2019;10 (3) :639-649.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC680270-500 1x 500 µL
Fibronectin (HFN7.1), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470460-500 1x 500 µL
CD44 Standard (156-3C11), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400734-500 1x 500 µL
TAG-72 / CA72.4 (B72.3 + CA72/733), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC471927-100 1x 100 µL
SOX9 / SRY-box 9 (PCRP-SOX9-1A2), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details